Baby / Drugs / Arthritis / Rheumatoid Arthritis

SELECT-PsA 2: Upadacitinib maintains efficacy against PsA at 1 year

Posted on: Jun 11, 2021   |   Posted by: Master Doctor

SELECT-PsA 2: Upadacitinib maintains efficacy against PsA at 1 year

Upadacitinib maintains its efficacy over 56 weeks in patients with psoriatic arthritis who had a prior inadequate response to at least one biologic disease-modifying...

Continue reading ...